The majority of women in the united states are taking prescription medications that are effected by their hormonal cycle. In addition, the majority of medications we use today were approved in trials where women were not included. With the latest AI tools and digital biomarkers, it is finally possible to deliver a solution based on ambient intelligence. This means that women can focus on their busy lives while providing their physicians with the clinical decision making insights that improve their outcomes. Pharmaceutical companies have started working towards closing the gender health equity gap, but lack the tools to deliver precision medication to women.